Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder

British Journal of Haematology

Volumn 143, Issue 4, 2008, Pages 496-502

  Vermeersch, Pieter ^a   Van Hoovels, Lieve ^a   Delforge, Michel ^a   Mariën, Godelieve ^a   Bossuyt, Xavier ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

B cells; Haemotological malignancies; Immunohaemotology; Multiple myeloma

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; NONHODGKIN LYMPHOMA; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; SENSITIVITY AND SPECIFICITY; URINALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 54849422427     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07369.x     Document Type: Article

References (14)

1. Bakshi, N.A., Gulbranson, R., Garstka, D., Bradwell, A.R. Keren, D.F. (2005) Serum free light chain (FLC) measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins. American Journal of Clinical Pathology, 124, 214 218.
2. Beetham, R., Wassell, J., Wallage, M.J., Whiteway, A.J. James, J.A. (2007) Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies? Annals of Clinical Biochemistry, 44, 516 522.
3. Bradwell, A.R., Carr-Smith, H.D., Mead, G.P., Harvey, T.C. Drayson, M.T. (2003) Serum test for assessment of patients with Bence Jones myeloma. Lancet, 361, 489 491.
4. Hill, P.G., Forsyth, J.M., Rai, B. Mayne, S. (2006) Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies. Clinical Chemistry, 52, 1743 1748.
5. Katzmann, J.A. (2006) Serum free light chain specificity and sensitivity: a reality check. Clinical Chemistry, 52, 1638 1639.
6. Katzmann, J.A., Clark, R.J., Abraham, R.S., Bryant, S., Lymp, J.F., Bradwell, A.R. Kyle, R.A. (2002) Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clinical Chemistry, 48, 1437 1444.
7. Katzmann, J.A., Abraham, R.S., Dispenzieri, A., Lust, J.A. Kyle, R.A. (2005) Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clinical Chemistry, 51, 878 881.
8. Katzmann, J.A., Dispenzieri, A., Kyle, R.A., Snyder, M.R., Plevak, M.F., Larson, D.R., Abraham, R.S., Lust, J.A., Melton, III., L.J. Rajkumar, S.V. (2006) Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays. Mayo Clinic Proceedings, 81, 1575 1578.
9. Marien, G., Oris, E., Bradwell, A.R., Blanckaert, N. Bossuyt, X. (2002) Detection of monoclonal proteins in sera by capillary zone electrophoresis and free light chain measurements. Clinical Chemistry, 48, 1600 1601.
10. Pratt, G. (2008) The evolving use of serum free light chain assays in haematology. British Journal of Haematology, 141, 413 422.
11. Rajkumar, S.V., Kyle, R.A., Therneau, T.M., Melton, Jr., L., Bradwell, A.R., Clark, R.J., Larson, D.R., Plevak, M.F., Dispenzieri, A. Katzmann, J.A. (2005) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood, 106, 812 817.
12. Smith, A., Wisloff, F. Samson, D. (2006) Guidelines on the diagnosis and management of multiple myeloma 2005. British Journal Haematology, 132, 410 451.
13. The International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. British Journal of Haematology, 121, 749 757.
14. Vermeersch, P., Marien, G. Bossuyt, X. (2008) More studies are needed to assess the performance of serum free light chain measurement for the diagnosis of B-cell disorders in routine clinical practice. British Journal of Haematology in press).